What is Amylyx Pharmaceuticals, Inc.'s investing cash flow?

Amylyx Pharmaceuticals, Inc. (AMLX) reported investing cash flow of $36.26M in Q1 2026.

How has Amylyx Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?

Amylyx Pharmaceuticals, Inc.'s investing cash flow increased by 183.1% year-over-year, from -$43.66M to $36.26M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Amylyx Pharmaceuticals, Inc. AMLX Investing Cash Flow

Investing Cash Flow at other companies

MBX Biosciences, Inc.MBX

-$97.1M-3,110%

Viking TherapeuticsVKTX

$54.19M-14.3%

Beam TherapeuticsBEAM

$25.27M+120%

Crinetics PharmaceuticalsCRNX

-$252.36M-194%

Agios PharmaceuticalsAGIO

$141.31M+25.5%

Rhythm Pharmaceuticals, Inc.RYTM

$57.05M+130%

Other financials

Income statement

See full

Revenue-—

Gross profit-—

Operating income-$43.8M-15.8%

Net income-$41.3M-15.0%

EPS (diluted)-$0.37+11.9%

Balance sheet

See full

Cash & equivalents$229.1M+283%

Total debt$5.6M+307%

Total equity$273.2M+35.6%

Total assets$293.6M+33.7%

Cash flow

See full

Operating cash flow-$36.9M+7.4%

CapEx$86.0K+330%

Free cash flow-$28.0M+52.6%

Valuation

See full

Market cap$1.82B+390%

Enterprise value$1.6B+414%

Profitability

See full

Gross margin100%+6.9pp

Operating margin-47,349.8%-47,409pp

Net margin-45,096.2%-45,152pp

FCF margin-39,826.7%-39,847pp

Returns & leverage

See full

Return on equity-63.3%-12.2pp

Debt / equity0×0.0×

Current ratio17.9×+5.8×

Where this comes from

Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s investing cash flow?: Amylyx Pharmaceuticals, Inc. (AMLX) reported investing cash flow of $36.26M in Q1 2026.
How has Amylyx Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?: Amylyx Pharmaceuticals, Inc.'s investing cash flow increased by 183.1% year-over-year, from -$43.66M to $36.26M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.